Sarah Harkcom, General Counsel at Scientist.com, Wins European Legal Innovation & Technology 'Innovation Trailblazer' Award
SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading R&D procurement-orchestration platform for the life sciences, today announced that its General Counsel, Sarah Harkcom, has been named Innovation Trailblazer at the 2025 European Legal Innovation & Technology Awards.
Scientist.com's legal framework has supported more than $2.5 billion in outsourced research, enabling scientists to launch critical experiments in days rather than weeks or months.
Share
Harkcom was recognized for architecting a unified, cross-border contracting model now adopted by many of the world's top pharmaceutical companies and contract research organizations (CROs). The framework has already supported more than $2.5 billion in outsourced research, enabling scientists to launch critical experiments in days rather than weeks or months.
'Sarah's vision reshaped how the pharma industry does business,' said Kevin Lustig, PhD, CEO and Founder of Scientist.com. 'Her streamlined legal model removes friction for both buyers and suppliers, giving researchers faster access to the services they need to discover life-changing cures.'
Key achievements
Industry standardization: Created global template agreements that underlie most Scientist.com transactions.
Accelerated R&D: Reduced contract-cycle times from months to days, a breakthrough that proved vital during the COVID-19 pandemic and continues to speed progress against other diseases.
Global impact: The model's cross-jurisdictional design delivers uniform compliance and efficiency for partners in 80 countries.
The awards ceremony took place on May 28 in Milan, Italy. For a full list of honorees, visit the European Legal Innovation & Technology Awards website.
About Scientist.com
Scientist.com makes it easy for life-science teams to find, vet and order the research services and products they need—often in days instead of weeks. Its online marketplace brings together 6,000+ pre-qualified suppliers across 1,000-plus research categories, all with built-in regulatory and data-privacy controls. The platform powers secure sourcing hubs for 20 of the world's top 30 pharmaceutical companies, 100+ biotech firms and the U.S. National Institutes of Health (NIH). Founded in 2007 and continually enhanced with AI tools, Scientist.com helps scientists spend less time on paperwork and more time on discovery. Learn more at https://www.scientist.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Trump Wants the Fed to Cut Interest Rates by a Full Point. That Normally Takes a Recession
President Donald Trump demanded the Federal Reserve lower its benchmark interest rate by an entire percentage point. The Fed, which operates independently of White House control, has resisted Trump's call to lower interest rates. Lower rates could boost the economy but risk igniting inflation. The Fed typically adjusts its interest rate a quarter point at a time: the last time it cut a full point was in March 2020 when the pandemic Donald Trump renewed his calls on the Federal Reserve to lower its benchmark interest rate Friday, and this time, he had a specific (and huge) ask in mind. In a series of social media posts Friday morning, Trump pointed to the economy's recent track record of solid job growth and cooling inflation, and taunted Federal Reserve Chair Jerome Powell for not having lowered interest rates sooner. Trump said the central bank should lower its influential fed funds rate by "a full point," saying it would be economic "Rocket Fuel!"The Fed adjusts its fed funds rate, which influences borrowing costs on all kinds of loans, to keep inflation down and employment high. Fed officials have kept their rate higher than usual so far this year in an effort to push inflation down to its goal of a 2% annual rate. Officials said they are waiting to see what happens in the economy because they are concerned Trump's tariffs could push up prices and set off a fresh round of Fed's cautious approach has angered Trump, who wants rate cuts and the economic growth they could promote. A full percentage point cut would be a major move by the Fed and would bring the fed funds rate to a range of 3.25% to 3.5%, its lowest since September 2022. The Fed typically moves rates a quarter-point at a time. The last time the Fed cut rates an entire percentage point was March 2020, when it was evident that the onset of the COVID-19 pandemic would thrash the economy. Before that, the Fed cut an entire point in December 2008, during the Great Recession. The posts were the latest moves in Trump's pressure campaign to influence the Fed's decision-making about monetary policy. The central bank is designed to be insulated from politics, and Powell has said the Fed's decisions will be based only on economic considerations. Trump has repeatedly criticized Powell for not lowering interest rates, in contrast to the Fed's European counterpart. The European Central Bank has cut rates eight times since last June. The Fed cut rates three times over that time period, including a jumbo half-point cut in September, but has kept rates flat. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine. With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty. This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. BANGKOK, June 06, 2025--(BUSINESS WIRE)--IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. As part of the congress, IBSA Derma will host a scientific symposium titled "The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line" scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead the session, focusing on the evolving approaches in regenerative aesthetic medicine, with particular attention to the clinical impact of hybrid cooperative complexes (HCCs) of hyaluronic acid and their role in tissue regeneration across different anatomical layers affected by aging. HCCs represent a new frontier in hyaluronic acid-based product formulation, made possible through NAHYCO® Technology, IBSA's patented thermal process that celebrates its 10th anniversary this year. This technological breakthrough is the foundation of the Profhilo® line and continues to be a milestone of IBSA Derma's innovation pathway. The Company's presence at IMCAS Asia is part of a broader strategic plan for expansion across the APAC region, an increasingly dynamic and high-potential market. In this context, IBSA Derma strengthened its regional presence last year with the opening of its regional hub in Singapore and the launch of a dedicated platform for Asian Key Opinion Leaders to share their clinical insights and expertise. "The strong growth we are experiencing in the APAC region stems from our solid collaboration with local distributors, which enable us to better understand the specific dynamics and cultural nuances of each market" – says Loy Derris, Business Development Director Dermoaesthetic Division North Asia. "Over the past 18 months, we have achieved remarkable results in countries such as Indonesia, Vietnam, Japan, and India, and we have recently entered the Thai market with great momentum. Looking ahead we are also looking enthusiastically toward promising new markets like Taiwan" – declares Magallon Riza Marie, Senior Strategic Marketing and Operational Lead Dermoaesthetic APAC Region. "Being at IMCAS Asia for the second year in a row is a valuable opportunity to strengthen our dialogue with physicians in the APAC Region and promote our concept of authentic beauty that embraces a holistic and overall wellness-oriented approach" – states Elisa Brozzelli, Brand Activation Manager Dermoaesthetic Division. IBSA Derma will also be present at Booth 8 - Level 2, where visitors can learn more about the latest solutions and innovations in aesthetic medicine. About IBSA IBSA (Institut Biochimique SA) is a Swiss pharmaceutical multinational with 20 subsidiaries across Europe, China, and the United States. Its products are available in over 90 countries, and its R&D activities focus on 10 therapeutic areas. In 2025, IBSA will celebrate the 40th anniversary of its acquisition by current President and CEO, Arturo Licenziati, who has transformed the company into a multinational corporation employing over 2,300 personnel worldwide. IBSA's growth and development can be attributed to its ability to innovate by refining well-known molecules, as well as to its commitment to looking to the future responsibly and transparently, thanks to the dedication and dynamism of its people. About IBSA Derma IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for aesthetic medicine based on hyaluronic acid, thus creating a dedicated division: IBSA Derma. Through scientific expertise, continuous research, technological development and a modern production process, IBSA has become one of the leading pharmaceutical companies to produce hyaluronic acid for aesthetic medicine applications. IBSA Derma distinguishes itself in this vast market because it controls the entire product lifecycle, from the biofermentation production of the raw material to the ready-to-use final product in prefilled syringes. View source version on Contacts For further information: Giulia Drei, PR and Communication SpecialistDermoaesthetic Sign in to access your portfolio
San Francisco Chronicle
24 minutes ago
- San Francisco Chronicle
Bay Area library visits have sharply declined. But not in this tranquil suburb
Across the Bay Area, libraries saw just about two-thirds as many visits per capita last year as they did seven years ago, a Chronicle analysis of state library data found. Most libraries in the nine Bay Area counties have yet to see visits climb back to pre-pandemic levels. Large public library systems like San Francisco, San Jose and Oakland are all still seeing about 30% fewer visits per capita than they used to. A handful of systems, though, have not only recovered — they've grown. The data comes from the California State Library, which surveys each public library system each year. To calculate visits per capita, the number of visits at a library in a given fiscal year is divided by the population of that system's service area. Declining visitation is virtually a universal problem. Almost no local public library system saw growth between the 2018-2019 and 2023-2024 fiscal years, the Chronicle found. The numbers are in keeping with national trends, according to a report by the Urban Libraries Council, an advocacy group. But those numbers aren't so bad when viewed in the context of other amenities post-pandemic. 'When you compare what's happening with libraries to what's going on in commercial (office) space, libraries are doing pretty well,' said Brooks Rainwater, the president of the Urban Libraries Council. And though they're still not at pre-pandemic levels, visits per capita in the Bay Area and nationally have been slowly ticking up since their shutdown-induced low points, said Rainwater. He compared the slow but steady recovery of libraries to shifts in all parts of city life, like transit ridership, office visits, tourism and retail shopping, all of which still have yet to reach what they were before COVID. And he expects the recovery will continue. Early data being collected for the council's 2025 report indicates that in-person library visits are up to about 75% of pre-pandemic levels. Part of the picture — and a reason for hope — is the shifting role of what a library is within a community, a change that was happening even before the pandemic, Rainwater said. While an increasing number of people are borrowing ebooks instead of physically checking out books, libraries are also increasingly used as a 'third space' for people to gather, to work or to just hang out, he said. 'Literacy and books are always going to be our stock and trade,' he said, 'but libraries are reflective of community needs.' That's a philosophy Anji Brenner, the city librarian at the Mill Valley Public Library, believes in wholeheartedly. The library, nestled among redwood trees and boasting floor-to-ceiling windows with views of the forest, a deck overlooking the nearby creek and even a wood-burning fireplace, is one of the few in the Bay Area to have fully recovered its visit numbers — an especially impressive feat given that its per capita visit rate was already one of the highest in the Bay Area. 'What's not to love about this place?' Brenner said. Brenner said the recovery didn't happen automatically: Staff worked hard to adapt programming during and after the pandemic. That has meant, for example, everything from author talks to nature walks, and experimenting with the times those programs are offered: Weekends have proven very popular. The library also hired a more diverse staff, which Brenner said helped it to engage with more members of the community. Likewise, Brenner also said that the demographics of visitors have shifted. Twenty- and thirty-somethings come to the library regularly now, a relatively new phenomenon, and teens, who were always reliable patrons, spend even more time there. It also helps that Mill Valley is rich. Brenner noted that both the Mill Valley Library Foundation and Friends of the Mill Valley Library fundraise for the public library. In general, library visits were higher in wealthier places like Marin County. Still, none of that matters if a library system isn't attuned to the community. 'You have to be grounded in who you're serving and why you're here,' she said. 'We want to bring joy to people's lives.'
